Herpesvirus: an underestimated virus.
Daniele Zendrini RechenchoskiLigia Carla Faccin-GalhardiRosa Elisa Carvalho LinharesCarlos NozawaPublished in: Folia microbiologica (2016)
Herpes simplex virus (HSV) infections are common and widespread; nevertheless, their outcome can be of unpredictable prognosis in neonates and in immunosuppressed patients. Anti-HSV therapy is effective, but the emergence of drug-resistant strains or the drug toxicity that hamper the treatment is of great concern. Vaccine has not yet shown relevant benefit; therefore, palliative prophylactic measures have been adopted to prevent diseases. This short review proposes to present concisely the history of HSV, its taxonomy, physical structure, and replication and to explore the pathogenesis of the infection, clinical manifestations, laboratory diagnosis, treatment, prophylaxis and epidemiology of the diseases.
Keyphrases
- herpes simplex virus
- drug resistant
- end stage renal disease
- multidrug resistant
- ejection fraction
- chronic kidney disease
- physical activity
- acinetobacter baumannii
- newly diagnosed
- escherichia coli
- palliative care
- mental health
- mesenchymal stem cells
- risk factors
- combination therapy
- patient reported outcomes
- stress induced
- low birth weight
- advanced cancer
- bone marrow
- patient reported